-
(
AmelioIMelinoG.
The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression. Trends Biochem Sci
2015; 40: 425–434.26032560)
AmelioIMelinoG.
The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression. Trends Biochem Sci
2015; 40: 425–434.26032560
,
AmelioIMelinoG.
The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression. Trends Biochem Sci
2015; 40: 425–434.26032560
-
M.
Gustafsson,
Xiaowei
Zheng,
T.
Pereira,
K.
Gradin,
Shaobo
Jin,
J.
Lundkvist,
J.
Ruas,
L.
Poellinger,
U.
Lendahl,
M.
Bondesson
(2005)
Hypoxia requires notch signaling to maintain the undifferentiated cell state.
Developmental cell, 9 5
-
(
EvangelouEIoannidisJP.
Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet
2013; 14: 379–389.23657481)
EvangelouEIoannidisJP.
Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet
2013; 14: 379–389.23657481
,
EvangelouEIoannidisJP.
Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet
2013; 14: 379–389.23657481
-
G.
Theodoropoulos,
A.
Lazaris,
V.
Theodoropoulos,
Kalliopi
Papatheodosiou,
M.
Gazouli,
J.
Bramis,
E.
Patsouris,
D.
Panoussopoulos
(2006)
Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer
International Journal of Colorectal Disease, 21
-
(
BerkVDenizKBozkurtO, et al
Predictive significance of VEGF and HIF-1alpha expression in patients with metastatic colorectal cancer receiving chemotherapy combinations with bevacizumab. Asian Pac J Cancer Prev
2015; 16: 6149–6154.26320510)
BerkVDenizKBozkurtO, et al
Predictive significance of VEGF and HIF-1alpha expression in patients with metastatic colorectal cancer receiving chemotherapy combinations with bevacizumab. Asian Pac J Cancer Prev
2015; 16: 6149–6154.26320510
,
BerkVDenizKBozkurtO, et al
Predictive significance of VEGF and HIF-1alpha expression in patients with metastatic colorectal cancer receiving chemotherapy combinations with bevacizumab. Asian Pac J Cancer Prev
2015; 16: 6149–6154.26320510
-
(
XieMHeCSHuangJK, et al
Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: a Southern China urology cancer consortium trial. Eur J Cancer
2015; 51: 595–603.25618828)
XieMHeCSHuangJK, et al
Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: a Southern China urology cancer consortium trial. Eur J Cancer
2015; 51: 595–603.25618828
,
XieMHeCSHuangJK, et al
Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: a Southern China urology cancer consortium trial. Eur J Cancer
2015; 51: 595–603.25618828
-
for
Diagnostics
(2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Nature Clinical Practice Oncology, 2
-
(
AltmanDGBlandJM.
How to obtain the confidence interval from a P value. BMJ
2011; 343: d2090.21824904)
AltmanDGBlandJM.
How to obtain the confidence interval from a P value. BMJ
2011; 343: d2090.21824904
,
AltmanDGBlandJM.
How to obtain the confidence interval from a P value. BMJ
2011; 343: d2090.21824904
-
D.
Moher,
A.
Liberati,
J.
Tetzlaff,
D.
Altman
(2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement
Open Medicine, 3
-
Haiquan
Lu,
Debangshu
Samanta,
Lisha
Xiang,
Huimin
Zhang,
Hongxia
Hu,
Ivan
Chen,
John
Bullen,
G.
Semenza
(2015)
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
Proceedings of the National Academy of Sciences, 112
-
Peng
Zhang,
Qing
Yao,
Ling
Lu,
Yun
Li,
Po-Ju
Chen,
C.
Duan
(2014)
Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia.
Cell reports, 6 6
-
J.
Koo,
Haeryoung
Kim
(2011)
Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary
Tumor Biology, 32
-
N.
Rohwer,
T.
Cramer
(2011)
Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 14 3
-
A.
Jemal,
F.
Bray,
Melissa
Center,
J.
Ferlay,
Elizabeth
Ward,
D.
Forman
(2011)
Global cancer statistics
CA: A Cancer Journal for Clinicians, 61
-
(
XiangZLZengZCFanJ, et al
The expression of HIF-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep
2012; 39: 2021–2029.21647551)
XiangZLZengZCFanJ, et al
The expression of HIF-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep
2012; 39: 2021–2029.21647551
,
XiangZLZengZCFanJ, et al
The expression of HIF-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep
2012; 39: 2021–2029.21647551
-
J.
Brok,
K.
Thorlund,
C.
Gluud,
J.
Wetterslev
(2008)
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses.
Journal of clinical epidemiology, 61 8
-
(
ZhangLYeSBLiZL, et al
Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients. Int J Clin Exp Pathol
2014; 7: 3887–3897.25120765)
ZhangLYeSBLiZL, et al
Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients. Int J Clin Exp Pathol
2014; 7: 3887–3897.25120765
,
ZhangLYeSBLiZL, et al
Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients. Int J Clin Exp Pathol
2014; 7: 3887–3897.25120765
-
(
WillersHAzzoliCGSantivasiWL, et al
Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer J
2013; 19: 200–207.23708066)
WillersHAzzoliCGSantivasiWL, et al
Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer J
2013; 19: 200–207.23708066
,
WillersHAzzoliCGSantivasiWL, et al
Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer J
2013; 19: 200–207.23708066
-
A.
Harris
(2002)
Hypoxia — a key regulatory factor in tumour growth
Nature Reviews Cancer, 2
-
A.
Ocaña,
F.
Vera-Badillo,
B.
Seruga,
A.
Templeton,
A.
Pandiella,
E.
Amir
(2013)
HER3 overexpression and survival in solid tumors: a meta-analysis.
Journal of the National Cancer Institute, 105 4
-
(
DienstmannRMasonMJSinicropeFA, et al
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol
2017; 28: 1023–1031.28453697)
DienstmannRMasonMJSinicropeFA, et al
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol
2017; 28: 1023–1031.28453697
,
DienstmannRMasonMJSinicropeFA, et al
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol
2017; 28: 1023–1031.28453697
-
(
EggerMDavey SmithGSchneiderM, et al
Bias in meta-analysis detected by a simple, graphical test. BMJ
1997; 315: 629–634.9310563)
EggerMDavey SmithGSchneiderM, et al
Bias in meta-analysis detected by a simple, graphical test. BMJ
1997; 315: 629–634.9310563
,
EggerMDavey SmithGSchneiderM, et al
Bias in meta-analysis detected by a simple, graphical test. BMJ
1997; 315: 629–634.9310563
-
M.
Xie,
Chao-sheng
He,
Jinkun
Huang,
Qizhan
Lin
(2015)
Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: a Southern China Urology Cancer Consortium Trial.
European journal of cancer, 51 5
-
(
GoosJAde CubaEMCoupeVM, et al
Glucose transporter 1 (SLC2A1) and vascular endothelial growth factor A (VEGFA) predict survival after resection of colorectal cancer liver metastasis. Ann Surg
2016; 263: 138–145.25563886)
GoosJAde CubaEMCoupeVM, et al
Glucose transporter 1 (SLC2A1) and vascular endothelial growth factor A (VEGFA) predict survival after resection of colorectal cancer liver metastasis. Ann Surg
2016; 263: 138–145.25563886
,
GoosJAde CubaEMCoupeVM, et al
Glucose transporter 1 (SLC2A1) and vascular endothelial growth factor A (VEGFA) predict survival after resection of colorectal cancer liver metastasis. Ann Surg
2016; 263: 138–145.25563886
-
D.
Generali,
A.
Berruti,
M.
Brizzi,
L.
Campo,
S.
Bonardi,
S.
Wigfield,
A.
Bersiga,
G.
Allevi,
M.
Milani,
S.
Aguggini,
Valeria
Gandolfi,
L.
Dogliotti,
A.
Bottini,
A.
Harris,
S.
Fox
(2006)
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 12 15
-
(
StrigariLPinnaroPCarliniP, et al
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model. Crit Rev Oncol Hematol
2016; 102: 101–110.27157527)
StrigariLPinnaroPCarliniP, et al
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model. Crit Rev Oncol Hematol
2016; 102: 101–110.27157527
,
StrigariLPinnaroPCarliniP, et al
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model. Crit Rev Oncol Hematol
2016; 102: 101–110.27157527
-
(
DerSimonianRKackerR.
Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials
2007; 28: 105–114.16807131)
DerSimonianRKackerR.
Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials
2007; 28: 105–114.16807131
,
DerSimonianRKackerR.
Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials
2007; 28: 105–114.16807131
-
(
GustafssonMVZhengXPereiraT, et al
Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell
2005; 9: 617–628.16256737)
GustafssonMVZhengXPereiraT, et al
Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell
2005; 9: 617–628.16256737
,
GustafssonMVZhengXPereiraT, et al
Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell
2005; 9: 617–628.16256737
-
(
McQuadeJLDanielCRHessKR, et al
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol
2018; 19: 310–322.29449192)
McQuadeJLDanielCRHessKR, et al
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol
2018; 19: 310–322.29449192
,
McQuadeJLDanielCRHessKR, et al
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol
2018; 19: 310–322.29449192
-
(
WuFZhangJLiuY, et al
HIF1alpha genetic variants and protein expressions determine the response to platinum based chemotherapy and clinical outcome in patients with advanced NSCLC. Cell Physiol Biochem
2013; 32: 1566–1576.24335195)
WuFZhangJLiuY, et al
HIF1alpha genetic variants and protein expressions determine the response to platinum based chemotherapy and clinical outcome in patients with advanced NSCLC. Cell Physiol Biochem
2013; 32: 1566–1576.24335195
,
WuFZhangJLiuY, et al
HIF1alpha genetic variants and protein expressions determine the response to platinum based chemotherapy and clinical outcome in patients with advanced NSCLC. Cell Physiol Biochem
2013; 32: 1566–1576.24335195
-
(
BurriPDjonovVAebersoldDM, et al
Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys
2003; 56: 494–501.12738326)
BurriPDjonovVAebersoldDM, et al
Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys
2003; 56: 494–501.12738326
,
BurriPDjonovVAebersoldDM, et al
Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys
2003; 56: 494–501.12738326
-
Jing
Xie,
Hui
Gao,
Jian-jun
Peng,
Yan-tao
Han,
Xue-hong
Chen,
Qixiao
Jiang,
Chunbo
Wang
(2015)
Hispidulin prevents hypoxia-induced epithelial-mesenchymal transition in human colon carcinoma cells.
American journal of cancer research, 5 3
-
(
WinterSCShahKAHanC, et al
The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer
2006; 107: 757–766.16826581)
WinterSCShahKAHanC, et al
The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer
2006; 107: 757–766.16826581
,
WinterSCShahKAHanC, et al
The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer
2006; 107: 757–766.16826581
-
K.
Thorlund,
P.
Devereaux,
J.
Wetterslev,
G.
Guyatt,
J.
Ioannidis,
L.
Thabane,
L.
Gluud,
B.
Als-Nielsen,
C.
Gluud
(2009)
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
International journal of epidemiology, 38 1
-
A.
Begg,
F.
Stewart,
C.
Vens
(2011)
Strategies to improve radiotherapy with targeted drugs
Nature Reviews Cancer, 11
-
P.
Moreno-Acosta,
A.
Vallard,
S.
Carrillo,
O.
Gamboa,
A.
Romero-Rojas,
M.
Molano,
J.
Acosta,
D.
Mayorga,
C.
Rancoule,
M.A.
Garcia,
M.
Mestre,
N.
Magné
(2017)
Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma
Radiation Oncology (London, England), 12
-
(
McShaneLMAltmanDGSauerbreiW, et al
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst
2005; 97: 1180–1184.16106022)
McShaneLMAltmanDGSauerbreiW, et al
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst
2005; 97: 1180–1184.16106022
,
McShaneLMAltmanDGSauerbreiW, et al
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst
2005; 97: 1180–1184.16106022
-
C.
Fraga,
M.
Oliveira,
Érica
Oliveira,
L.
Barros,
F.
Santos,
R.
Gomez,
A.
de-Paula,
A.
Guimarães
(2012)
A high HIF-1α expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients.
Oral oncology, 48 2
-
(
BeuselinckBVerbiestACouchyG, et al
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma. Acta Oncol
2018; 57: 498–508.29095068)
BeuselinckBVerbiestACouchyG, et al
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma. Acta Oncol
2018; 57: 498–508.29095068
,
BeuselinckBVerbiestACouchyG, et al
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma. Acta Oncol
2018; 57: 498–508.29095068
-
B.
Bachtiary,
M.
Schindl,
R.
Pötter,
B.
Dreier,
T.
Knocke,
J.
Hainfellner,
R.
Horvat,
P.
Birner
(2003)
Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 9 6
-
(
PalazonAGoldrathAWNizetV, et al
HIF transcription factors, inflammation, and immunity. Immunity
2014; 41: 518–528.25367569)
PalazonAGoldrathAWNizetV, et al
HIF transcription factors, inflammation, and immunity. Immunity
2014; 41: 518–528.25367569
,
PalazonAGoldrathAWNizetV, et al
HIF transcription factors, inflammation, and immunity. Immunity
2014; 41: 518–528.25367569
-
Lin
Zhang,
Shu-Biao
Ye,
Ze-Lei
Li,
Gang
Ma,
Shi-ping
Chen,
Jia
He,
Wan-li
Liu,
D.
Xie,
Y.
Zeng,
Jiang
Li
(2014)
Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.
International journal of clinical and experimental pathology, 7 7
-
I.
Lohse,
Corey
Lourenco,
E.
Ibrahimov,
M.
Pintilie,
M.
Tsao,
D.
Hedley
(2014)
Assessment of Hypoxia in the Stroma of Patient-Derived Pancreatic Tumor Xenografts
Cancers, 6
-
(
XieJGaoHPengJ, et al
Hispidulin prevents hypoxia-induced epithelial-mesenchymal transition in human colon carcinoma cells. Am J Cancer Res
2015; 5: 1047–1061.26045985)
XieJGaoHPengJ, et al
Hispidulin prevents hypoxia-induced epithelial-mesenchymal transition in human colon carcinoma cells. Am J Cancer Res
2015; 5: 1047–1061.26045985
,
XieJGaoHPengJ, et al
Hispidulin prevents hypoxia-induced epithelial-mesenchymal transition in human colon carcinoma cells. Am J Cancer Res
2015; 5: 1047–1061.26045985
-
Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American society of clinical oncology endorsement of the college of American pathologists/international association for the study of lung cancer/association for molecular pathology clinical practice guideline update
-
Caroline
Wigerup,
S.
Påhlman,
D.
Bexell
(2016)
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
Pharmacology & therapeutics, 164
-
(
HarrisAL.
Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer
2002; 2: 38–47.11902584)
HarrisAL.
Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer
2002; 2: 38–47.11902584
,
HarrisAL.
Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer
2002; 2: 38–47.11902584
-
(
BeggCBMazumdarM.
Operating characteristics of a rank correlation test for publication bias. Biometrics
1994; 50: 1088–1101.7786990)
BeggCBMazumdarM.
Operating characteristics of a rank correlation test for publication bias. Biometrics
1994; 50: 1088–1101.7786990
,
BeggCBMazumdarM.
Operating characteristics of a rank correlation test for publication bias. Biometrics
1994; 50: 1088–1101.7786990
-
H.
Willers,
C.
Azzoli,
Wil
Santivasi,
F.
Xia
(2013)
Basic Mechanisms of Therapeutic Resistance to Radiation and Chemotherapy in Lung Cancer
The Cancer Journal, 19
-
Kimberly
Corbin,
Hedy
Kindler,
S.
Liauw
(2014)
Considering the role of radiation therapy for gastrointestinal stromal tumor
OncoTargets and therapy, 7
-
Zuo-Lin
Xiang,
Z.
Zeng,
Jia
Fan,
Zhao-You
Tang,
Jian
He,
H.
Zeng,
Joe
Chang
(2012)
The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome
Molecular Biology Reports, 39
-
(
ThorlundKDevereauxPJWetterslevJ, et al
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Int J Epidemiol
2009; 38: 276–286.18824467)
ThorlundKDevereauxPJWetterslevJ, et al
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Int J Epidemiol
2009; 38: 276–286.18824467
,
ThorlundKDevereauxPJWetterslevJ, et al
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Int J Epidemiol
2009; 38: 276–286.18824467
-
C.
Begg,
Madhuchhanda
Mazumdar
(1994)
Operating characteristics of a rank correlation test for publication bias.
Biometrics, 50 4
-
(
SamantaDGilkesDMChaturvediP, et al
Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci U S A
2014; 111: E5429–E5438.25453096)
SamantaDGilkesDMChaturvediP, et al
Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci U S A
2014; 111: E5429–E5438.25453096
,
SamantaDGilkesDMChaturvediP, et al
Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci U S A
2014; 111: E5429–E5438.25453096
-
(
TorreLABrayFSiegelRL, et al
Global cancer statistics, 2012. CA Cancer J Clin
2015; 65: 87–108.25651787)
TorreLABrayFSiegelRL, et al
Global cancer statistics, 2012. CA Cancer J Clin
2015; 65: 87–108.25651787
,
TorreLABrayFSiegelRL, et al
Global cancer statistics, 2012. CA Cancer J Clin
2015; 65: 87–108.25651787
-
G.
Heestand,
James
Murphy,
J.
Moughan,
W.
Regine,
Jia
Luo,
M.
Graber,
P.
Kunz,
G.
Fisher,
C.
Guha,
B.
Lin,
R.
Mowat,
R.
Gaur,
M.
Buyyounouski,
Yuhchyau
Chen,
D.
Chang,
A.
Koong
(2014)
A novel biomarker panel examining response to adjuvant pancreatic cancer therapy in RTOG 9704.
Journal of Clinical Oncology, 32
-
(
MoherDLiberatiATetzlaffJ, et al
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ
2009; 339: b2535.19622551)
MoherDLiberatiATetzlaffJ, et al
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ
2009; 339: b2535.19622551
,
MoherDLiberatiATetzlaffJ, et al
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ
2009; 339: b2535.19622551
-
(
TheodoropoulosGELazarisACTheodoropoulosVE, et al
Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis
2006; 21: 248–257.16052307)
TheodoropoulosGELazarisACTheodoropoulosVE, et al
Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis
2006; 21: 248–257.16052307
,
TheodoropoulosGELazarisACTheodoropoulosVE, et al
Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis
2006; 21: 248–257.16052307
-
(
KlatteTSeligsonDBRiggsSB, et al
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res
2007; 13: 7388–7393.18094421)
KlatteTSeligsonDBRiggsSB, et al
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res
2007; 13: 7388–7393.18094421
,
KlatteTSeligsonDBRiggsSB, et al
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res
2007; 13: 7388–7393.18094421
-
C.
Maes,
G.
Carmeliet,
E.
Schipani
(2012)
Hypoxia-driven pathways in bone development, regeneration and disease
Nature Reviews Rheumatology, 8
-
(
WanXBFanXJHuangPY, et al
Aurora-A activation, correlated with hypoxia-inducible factor-1alpha, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma. Cancer Sci
2012; 103: 1586–1594.22587416)
WanXBFanXJHuangPY, et al
Aurora-A activation, correlated with hypoxia-inducible factor-1alpha, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma. Cancer Sci
2012; 103: 1586–1594.22587416
,
WanXBFanXJHuangPY, et al
Aurora-A activation, correlated with hypoxia-inducible factor-1alpha, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma. Cancer Sci
2012; 103: 1586–1594.22587416
-
(
WigerupCPahlmanSBexellD.
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther
2016; 164: 152–169.27139518)
WigerupCPahlmanSBexellD.
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther
2016; 164: 152–169.27139518
,
WigerupCPahlmanSBexellD.
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther
2016; 164: 152–169.27139518
-
Debangshu
Samanta,
Daniele
Gilkes,
P.
Chaturvedi,
Lisha
Xiang,
G.
Semenza
(2014)
Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
Proceedings of the National Academy of Sciences, 111
-
(
ZhangPYaoQLuL, et al
Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia. Cell Rep
2014; 6: 1110–1121.24613356)
ZhangPYaoQLuL, et al
Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia. Cell Rep
2014; 6: 1110–1121.24613356
,
ZhangPYaoQLuL, et al
Hypoxia-inducible factor 3 is an oxygen-dependent transcription activator and regulates a distinct transcriptional response to hypoxia. Cell Rep
2014; 6: 1110–1121.24613356
-
R.
Dienstmann,
R.
Dienstmann,
M.
Mason,
F.
Sinicrope,
A.
Phipps,
S.
Tejpar,
A.
Nesbakken,
S.
Danielsen,
A.
Sveen,
D.
Buchanan,
D.
Buchanan,
M.
Clendenning,
C.
Rosty,
B.
Bot,
S.
Alberts,
J.
Jessup,
R.
Lothe,
M.
Delorenzi,
P.
Newcomb,
D.
Sargent,
J.
Guinney
(2017)
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
Annals of Oncology, 28
-
J.
McQuade,
C.
Daniel,
K.
Hess,
Carmen
Mak,
Daniel
Wang,
R.
Rai,
John
Park,
L.
Haydu,
C.
Spencer,
M.
Wongchenko,
S.
Lane,
Dung-Yang
Lee,
M.
Kaper,
M.
McKean,
K.
Beckermann,
S.
Rubinstein,
I.
Rooney,
L.
Musib,
N.
Budha,
J.
Hsu,
T.
Nowicki,
A.
Avila,
T.
Haas,
M.
Puligandla,
Sandra
Lee,
S.
Fang,
J.
Wargo,
J.
Gershenwald,
Jeffrey
Lee,
P.
Hwu,
P.
Chapman,
J.
Sosman,
D.
Schadendorf,
J.
Grob,
K.
Flaherty,
D.
Walker,
Yibing
Yan,
E.
McKenna,
J.
Legos,
M.
Carlino,
A.
Ribas,
J.
Kirkwood,
G.
Long,
Douglas
Johnson,
A.
Menzies,
M.
Davies
(2018)
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.
The Lancet. Oncology, 19 3
-
E.
Zintzaras,
J.
Ioannidis
(2005)
HEGESMA: genome search meta-analysis and heterogeneity testing
Bioinformatics, 21 18
-
P.
Burri,
V.
Djonov,
D.
Aebersold,
K.
Lindel,
U.
Studer,
H.
Altermatt,
L.
Mazzucchelli,
R.
Greiner,
G.
Gruber
(2003)
Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy.
International journal of radiation oncology, biology, physics, 56 2
-
(2007)
Hypoxiainducible factor 1 alpha in clear cell renal cell carcinoma
-
(
RankinEBGiacciaAJ.
Hypoxic control of metastasis. Science
2016; 352: 175–180.27124451)
RankinEBGiacciaAJ.
Hypoxic control of metastasis. Science
2016; 352: 175–180.27124451
,
RankinEBGiacciaAJ.
Hypoxic control of metastasis. Science
2016; 352: 175–180.27124451
-
(
HindDTappendenPTumurI, et al
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess
2008; 12: iii–ix, xi–162.)
HindDTappendenPTumurI, et al
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess
2008; 12: iii–ix, xi–162.
,
HindDTappendenPTumurI, et al
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technol Assess
2008; 12: iii–ix, xi–162.
-
H.
Nyström,
Mats
Jönsson,
L.
Werner-Hartman,
M.
Nilbert,
M.
Nilbert,
Ana
Carneiro
(2017)
Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall
Journal of Clinical Pathology, 70
-
(
DellasKBacheMPigorschSU, et al
Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol
2008; 184: 169–174.)
DellasKBacheMPigorschSU, et al
Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol
2008; 184: 169–174.
,
DellasKBacheMPigorschSU, et al
Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol
2008; 184: 169–174.
-
M.
Shimomura,
T.
Hinoi,
S.
Kuroda,
T.
Adachi,
Y.
Kawaguchi,
T.
Sasada,
Y.
Takakura,
H.
Egi,
M.
Okajima,
H.
Tashiro,
T.
Nishizaka,
H.
Ohdan
(2013)
Overexpression of Hypoxia Inducible Factor-1 Alpha is an Independent Risk Factor for Recurrence After Curative Resection of Colorectal Liver Metastases
Annals of Surgical Oncology, 20
-
(
JochmanovaIYangCZhuangZ, et al
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst
2013; 105: 1270–1283.23940289)
JochmanovaIYangCZhuangZ, et al
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst
2013; 105: 1270–1283.23940289
,
JochmanovaIYangCZhuangZ, et al
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst
2013; 105: 1270–1283.23940289
-
M.
Schindl,
S.
Schoppmann,
H.
Samonigg,
H.
Hausmaninger,
W.
Kwasny,
M.
Gnant,
R.
Jakesz,
E.
Kubista,
P.
Birner,
G.
Oberhuber
(2002)
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 8 6
-
(
ZintzarasEIoannidisJP.
HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics
2005; 21: 3672–3673.15955784)
ZintzarasEIoannidisJP.
HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics
2005; 21: 3672–3673.15955784
,
ZintzarasEIoannidisJP.
HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics
2005; 21: 3672–3673.15955784
-
A.
Palazón,
A.
Goldrath,
V.
Nizet,
R.
Johnson
(2014)
HIF transcription factors, inflammation, and immunity.
Immunity, 41 4
-
B.
Shim,
J.
Jung,
Kang-Moon
Lee,
Hyung-Jin
Kim,
S.
Hong,
Sung
Kim,
D.
Sun,
Hyeon-Min
Cho
(2013)
Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer
International Journal of Colorectal Disease, 28
-
V.
Berk,
K.
Deniz,
O.
Bozkurt,
E.
Ozaslan,
H.
Karaca,
M.
Inanc,
A.
Duran,
M.
Ozkan
(2015)
Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab.
Asian Pacific journal of cancer prevention : APJCP, 16 14
-
(
BachtiaryBSchindlMPotterR, et al
Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res
2003; 9: 2234–2240.12796391)
BachtiaryBSchindlMPotterR, et al
Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res
2003; 9: 2234–2240.12796391
,
BachtiaryBSchindlMPotterR, et al
Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res
2003; 9: 2234–2240.12796391
-
J.
Gordan,
Craig B.
Thompson,
M.
Simon
(2007)
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.
Cancer cell, 12 2
-
(
FurukawaTMiyataYKushitaniK, et al
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1alpha and glucose transporter 1 in non-small cell lung cancer. Jpn J Clin Oncol
2015; 45: 1154–1161.26386467)
FurukawaTMiyataYKushitaniK, et al
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1alpha and glucose transporter 1 in non-small cell lung cancer. Jpn J Clin Oncol
2015; 45: 1154–1161.26386467
,
FurukawaTMiyataYKushitaniK, et al
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1alpha and glucose transporter 1 in non-small cell lung cancer. Jpn J Clin Oncol
2015; 45: 1154–1161.26386467
-
E.
Rankin,
A.
Giaccia
(2016)
Hypoxic control of metastasis
Science, 352
-
F.
Agani,
B.
Jiang
(2013)
Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer.
Current cancer drug targets, 13 3
-
B.
Miladinovic,
R.
Mhaskar,
I.
Hozo,
Ambuj
Kumar,
H.
Mahony,
B.
Djulbegovic
(2013)
Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error.
Journal of clinical epidemiology, 66 6
-
(
BalamuruganK.
HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer
2016; 138: 1058–1066.25784597)
BalamuruganK.
HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer
2016; 138: 1058–1066.25784597
,
BalamuruganK.
HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer
2016; 138: 1058–1066.25784597
-
(
GordanJDThompsonCBSimonMC.
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell
2007; 12: 108–113.17692803)
GordanJDThompsonCBSimonMC.
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell
2007; 12: 108–113.17692803
,
GordanJDThompsonCBSimonMC.
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell
2007; 12: 108–113.17692803
-
HIF1alpha is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium
-
(
LohseILourencoCIbrahimovE, et al
Assessment of hypoxia in the stroma of patient-derived pancreatic tumor xenografts. Cancers (Basel)
2014; 6: 459–471.24577243)
LohseILourencoCIbrahimovE, et al
Assessment of hypoxia in the stroma of patient-derived pancreatic tumor xenografts. Cancers (Basel)
2014; 6: 459–471.24577243
,
LohseILourencoCIbrahimovE, et al
Assessment of hypoxia in the stroma of patient-derived pancreatic tumor xenografts. Cancers (Basel)
2014; 6: 459–471.24577243
-
(
ShimBYJungJHLeeKM, et al
Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer. Int J Colorectal Dis
2013; 28: 375–383.22847606)
ShimBYJungJHLeeKM, et al
Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer. Int J Colorectal Dis
2013; 28: 375–383.22847606
,
ShimBYJungJHLeeKM, et al
Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer. Int J Colorectal Dis
2013; 28: 375–383.22847606
-
J.
García-Donas,
L.
Leandro-García,
A.
Alba,
M.
Morente,
I.
Alemany,
E.
Esteban,
J.
Arranz,
M.
Climent,
E.
Gallardo,
D.
Castellano,
J.
Bellmunt,
B.
Mellado,
J.
Puente,
F.
Moreno,
A.
Font,
S.
Hernando,
M.
Robledo,
C.
Rodríguez‐Antona
(2013)
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology, 24 9
-
A.
Giatromanolaki,
M.
Koukourakis,
E.
Sivridis,
H.
Turley,
K.
Talks,
F.
Pezzella,
K.
Gatter,
A.
Harris
(2001)
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
British Journal of Cancer, 85
-
M.
Egger,
G.
Smith,
Martin
Schneider,
C.
Minder
(1997)
Bias in meta-analysis detected by a simple, graphical test
BMJ, 315
-
R.
Dersimonian,
R.
Kacker
(2007)
Random-effects model for meta-analysis of clinical trials: an update.
Contemporary clinical trials, 28 2
-
(
NyströmHJonssonMWerner-HartmanL, et al
Hypoxia-inducible factor 1alpha predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall. J Clin Pathol
2017; 70: 879–885.28404817)
NyströmHJonssonMWerner-HartmanL, et al
Hypoxia-inducible factor 1alpha predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall. J Clin Pathol
2017; 70: 879–885.28404817
,
NyströmHJonssonMWerner-HartmanL, et al
Hypoxia-inducible factor 1alpha predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall. J Clin Pathol
2017; 70: 879–885.28404817
-
I.
Amelio,
G.
Melino
(2015)
The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression.
Trends in biochemical sciences, 40 8
-
(
WilsonPMYangDAzumaM, et al
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib). Pharmacogenomics J
2013; 13: 410–416.22664478)
WilsonPMYangDAzumaM, et al
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib). Pharmacogenomics J
2013; 13: 410–416.22664478
,
WilsonPMYangDAzumaM, et al
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib). Pharmacogenomics J
2013; 13: 410–416.22664478
-
L.
Marignol,
Karla
Rivera-Figueroa,
T.
Lynch,
D.
Hollywood
(2013)
Hypoxia, notch signalling, and prostate cancer
Nature Reviews Urology, 10
-
(
AganiFJiangBH.
Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr Cancer Drug Targets
2013; 13: 245–251.23297826)
AganiFJiangBH.
Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr Cancer Drug Targets
2013; 13: 245–251.23297826
,
AganiFJiangBH.
Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr Cancer Drug Targets
2013; 13: 245–251.23297826
-
E.
Evangelou,
J.
Ioannidis
(2013)
Meta-analysis methods for genome-wide association studies and beyond
Nature Reviews Genetics, 14
-
J.
Tierney,
L.
Stewart,
D.
Ghersi,
S.
Burdett,
M.
Sydes
(2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Trials, 8
-
(
BeggACStewartFAVensC.
Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer
2011; 11: 239–253.21430696)
BeggACStewartFAVensC.
Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer
2011; 11: 239–253.21430696
,
BeggACStewartFAVensC.
Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer
2011; 11: 239–253.21430696
-
K.
Dellas,
M.
Bache,
S.
Pigorsch,
H.
Taubert,
M.
Kappler,
D.
Holzapfel,
Ester
Zorn,
H.
Holzhausen,
G.
Haensgen
(2008)
Prognostic Impact of HIF-1α Expression in Patients with Definitive Radiotherapy for Cervical Cancer
Strahlentherapie und Onkologie, 184
-
(
TierneyJFStewartLAGhersiD, et al
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials
2007; 8: 16.17555582)
TierneyJFStewartLAGhersiD, et al
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials
2007; 8: 16.17555582
,
TierneyJFStewartLAGhersiD, et al
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials
2007; 8: 16.17555582
-
Shang-Wen
Chen,
Wei-Chih
Shen,
Ying-Chun
Lin,
Rui-Yun
Chen,
Te-Chun
Hsieh,
Kuo‐Yang
Yen,
C.
Kao
(2017)
Correlation of pretreatment 18F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes
European Journal of Nuclear Medicine and Molecular Imaging, 44
-
Lindsey
Torre,
F.
Bray,
R.
Siegel,
J.
Ferlay,
J.
Lortet-Tieulent,
A.
Jemal
(2015)
Global cancer statistics, 2012
CA: A Cancer Journal for Clinicians, 65
-
(
MarignolLRivera-FigueroaKLynchT, et al
Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol
2013; 10: 405–413.23712204)
MarignolLRivera-FigueroaKLynchT, et al
Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol
2013; 10: 405–413.23712204
,
MarignolLRivera-FigueroaKLynchT, et al
Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol
2013; 10: 405–413.23712204
-
D.
Altman,
J.
Bland
(2011)
How to obtain the confidence interval from a P value
BMJ : British Medical Journal, 343
-
(
KooJSKimH.
Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary. Tumour Biol
2011; 32: 893–904.21598042)
KooJSKimH.
Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary. Tumour Biol
2011; 32: 893–904.21598042
,
KooJSKimH.
Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary. Tumour Biol
2011; 32: 893–904.21598042
-
I.
Jochmanova,
Chunzhang
Yang,
Z.
Zhuang,
K.
Pacak
(2013)
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.
Journal of the National Cancer Institute, 105 17
-
Jeroen
Goos,
E.
Cuba,
V.
Coupé,
B.
Diosdado,
P.
Diemen,
C.
Karga,
J.
Beliën,
C.
Oordt,
A.
Geldof,
Gerrit
Meijer,
Otto
Hoekstra,
R.
Fijneman
(2016)
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
Annals of surgery, 263 1
-
S.
Winter,
K.
Shah,
Cheng
Han,
L.
Campo,
H.
Turley,
R.
Leek,
R.
Corbridge,
G.
Cox,
A.
Harris
(2006)
The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Cancer, 107 4
-
T.
Furukawa,
Y.
Miyata,
K.
Kushitani,
T.
Mimae,
Y.
Tsutani,
Y.
Takeshima,
M.
Okada
(2015)
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer
Journal of Cardiothoracic Surgery, 10
-
P.
Wilson,
D.
Yang,
M.
Azuma,
M.
Shi,
K.
Danenberg,
D.
Lebwohl,
A.
Sherrod,
R.
Ladner,
W.
Zhang,
P.
Danenberg,
T.
Trarbach,
G.
Folprecht,
G.
Meinhardt,
H.
Lenz
(2012)
Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib)
The Pharmacogenomics Journal, 13
-
(
MaesCCarmelietGSchipaniE.
Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol
2012; 8: 358–366.22450551)
MaesCCarmelietGSchipaniE.
Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol
2012; 8: 358–366.22450551
,
MaesCCarmelietGSchipaniE.
Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol
2012; 8: 358–366.22450551
-
(
LuHSamantaDXiangL, et al
Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc Natl Acad Sci U S A
2015; 112: E4600–E4609.26229077)
LuHSamantaDXiangL, et al
Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc Natl Acad Sci U S A
2015; 112: E4600–E4609.26229077
,
LuHSamantaDXiangL, et al
Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc Natl Acad Sci U S A
2015; 112: E4600–E4609.26229077
-
(
ShioyaMTakahashiTIshikawaH, et al
Expression of hypoxia-inducible factor 1alpha predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer. J Radiat Res
2011; 52: 821–827.22104271)
ShioyaMTakahashiTIshikawaH, et al
Expression of hypoxia-inducible factor 1alpha predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer. J Radiat Res
2011; 52: 821–827.22104271
,
ShioyaMTakahashiTIshikawaH, et al
Expression of hypoxia-inducible factor 1alpha predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer. J Radiat Res
2011; 52: 821–827.22104271
-
(
BrokJThorlundKGluudC, et al
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol
2008; 61: 763–769.18411040)
BrokJThorlundKGluudC, et al
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol
2008; 61: 763–769.18411040
,
BrokJThorlundKGluudC, et al
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol
2008; 61: 763–769.18411040
-
(
ChenSWShenWCLinYC, et al
Correlation of pretreatment (18)F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes. Eur J Nucl Med Mol Imaging
2017; 44: 567–580.27999896)
ChenSWShenWCLinYC, et al
Correlation of pretreatment (18)F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes. Eur J Nucl Med Mol Imaging
2017; 44: 567–580.27999896
,
ChenSWShenWCLinYC, et al
Correlation of pretreatment (18)F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes. Eur J Nucl Med Mol Imaging
2017; 44: 567–580.27999896
-
(
BeasleyNJLeekRAlamM, et al
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res
2002; 62: 2493–2497.11980639)
BeasleyNJLeekRAlamM, et al
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res
2002; 62: 2493–2497.11980639
,
BeasleyNJLeekRAlamM, et al
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res
2002; 62: 2493–2497.11980639
-
(
BraicuEILuketinaHRichterR, et al
HIF1alpha is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium. Onco Targets Ther
2014; 7: 1563–1569.25246800)
BraicuEILuketinaHRichterR, et al
HIF1alpha is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium. Onco Targets Ther
2014; 7: 1563–1569.25246800
,
BraicuEILuketinaHRichterR, et al
HIF1alpha is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium. Onco Targets Ther
2014; 7: 1563–1569.25246800
-
L.
Strigari,
P.
Pinnaró,
P.
Carlini,
F.
Torino,
S.
Strolin,
S.
Minosse,
G.
Sanguineti,
M.
Benassi
(2016)
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model.
Critical reviews in oncology/hematology, 102
-
(
GeneraliDBerrutiABrizziMP, et al
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res
2006; 12: 4562–4568.16899602)
GeneraliDBerrutiABrizziMP, et al
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res
2006; 12: 4562–4568.16899602
,
GeneraliDBerrutiABrizziMP, et al
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res
2006; 12: 4562–4568.16899602
-
Fenglei
Wu,
Jian
Zhang,
Yi
Liu,
Y.
Zheng,
Nan
Hu
(2013)
HIF1α Genetic Variants and Protein Expressions Determine the Response to Platinum Based Chemotherapy and Clinical Outcome in Patients with Advanced NSCLC
Cellular Physiology and Biochemistry, 32
-
Daniel
Hind,
P.
Tappenden,
I.
Tumur,
S.
Eggington,
Paul
Sutcliffe,
Anthony
Ryan
(2008)
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
Health technology assessment, 12 15
-
(
ShimomuraMHinoiTKurodaS, et al
Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases. Ann Surg Oncol
2013; 20(Suppl. 3): S527–S536.23748663)
ShimomuraMHinoiTKurodaS, et al
Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases. Ann Surg Oncol
2013; 20(Suppl. 3): S527–S536.23748663
,
ShimomuraMHinoiTKurodaS, et al
Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases. Ann Surg Oncol
2013; 20(Suppl. 3): S527–S536.23748663
-
N.
Beasley,
R.
Leek,
Mohammed
Alam,
H.
Turley,
G.
Cox,
K.
Gatter,
P.
Millard,
S.
Fuggle,
A.
Harris
(2002)
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.
Cancer research, 62 9
-
X.
Wan,
Xin-Juan
Fan,
Pei-yu
Huang,
D.
Dong,
Yan
Zhang,
Ming-Yuan
Chen,
J.
Xiang,
Jie
Xu,
Li
Liu,
Wei-hua
Zhou,
Yan-chun
Lv,
Xiang-yuan
Wu,
M.
Hong,
Quentin
Liu
(2012)
Aurora‐A activation, correlated with hypoxia‐inducible factor‐1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma
Cancer Science, 103
-
(
Moreno-AcostaPVallardACarrilloS, et al
Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma. Radiat Oncol
2017; 12: 120.28716107)
Moreno-AcostaPVallardACarrilloS, et al
Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma. Radiat Oncol
2017; 12: 120.28716107
,
Moreno-AcostaPVallardACarrilloS, et al
Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma. Radiat Oncol
2017; 12: 120.28716107
-
(
GiatromanolakiAKoukourakisMISivridisE, et al
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer
2001; 85: 881–890.11556841)
GiatromanolakiAKoukourakisMISivridisE, et al
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer
2001; 85: 881–890.11556841
,
GiatromanolakiAKoukourakisMISivridisE, et al
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer
2001; 85: 881–890.11556841
-
(
ShultzDBPaiJChiuW, et al
A novel biomarker panel examining response to gemcitabine with or without erlotinib for pancreatic cancer therapy in NCIC clinical trials group PA.3. PLoS One
2016; 11: e0147995.26808546)
ShultzDBPaiJChiuW, et al
A novel biomarker panel examining response to gemcitabine with or without erlotinib for pancreatic cancer therapy in NCIC clinical trials group PA.3. PLoS One
2016; 11: e0147995.26808546
,
ShultzDBPaiJChiuW, et al
A novel biomarker panel examining response to gemcitabine with or without erlotinib for pancreatic cancer therapy in NCIC clinical trials group PA.3. PLoS One
2016; 11: e0147995.26808546
-
(
SchindlMSchoppmannSFSamoniggH, et al
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res
2002; 8: 1831–1837.12060624)
SchindlMSchoppmannSFSamoniggH, et al
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res
2002; 8: 1831–1837.12060624
,
SchindlMSchoppmannSFSamoniggH, et al
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res
2002; 8: 1831–1837.12060624
-
D.
Shultz,
J.
Pai,
W.
Chiu,
K.
Ng,
Madeline
Hellendag,
G.
Heestand,
D.
Chang,
D.
Tu,
M.
Moore,
W.
Parulekar,
A.
Koong
(2016)
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3
PLoS ONE, 11
-
(
FragaCAde OliveiraMVde OliveiraES, et al
A high HIF-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol
2012; 48: 130–135.21945343)
FragaCAde OliveiraMVde OliveiraES, et al
A high HIF-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol
2012; 48: 130–135.21945343
,
FragaCAde OliveiraMVde OliveiraES, et al
A high HIF-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol
2012; 48: 130–135.21945343
-
S.
Winter,
K.
Shah,
Cheng
Han,
L.
Campo,
H.
Turley,
R.
Leek,
R.
Corbridge,
G.
Cox,
A.
Harris
(2006)
The relation between hypoxia‐inducible factor (HIF)‐1α and HIF‐2α expression with anemia and outcome in surgically treated head and neck cancer
Cancer, 107
-
Visit SAGE journals online journals.sagepub.com/ home/tam
-
(
RohwerNCramerT.
Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat
2011; 14: 191–201.21466972)
RohwerNCramerT.
Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat
2011; 14: 191–201.21466972
,
RohwerNCramerT.
Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updat
2011; 14: 191–201.21466972
-
G.
Kalemkerian,
N.
Narula,
E.
Kennedy,
W.
Biermann,
J.
Donington,
N.
Leighl,
M.
Lew,
J.
Pantelas,
S.
Ramalingam,
M.
Reck,
A.
Saqi,
M.
Simoff,
Navneet
Singh,
B.
Sundaram
(2018)
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecula
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36 9
-
B.
Beuselinck,
A.
Verbiest,
G.
Couchy,
S.
Job,
A.
Reyniès,
C.
Meiller,
M.
Albersen,
V.
Verkarre,
E.
Lerut,
A.
Méjean,
J.
Patard,
B.
Laguerre,
N.
Rioux-Leclercq,
P.
Schöffski,
S.
Oudard,
J.
Zucman‐Rossi
(2017)
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma
Acta Oncologica, 57
-
(
OcanaAVera-BadilloFSerugaB, et al
HER3 overexpression and survival in solid tumors: a meta-analysis. J Natl Cancer Inst
2013; 105: 266–273.23221996)
OcanaAVera-BadilloFSerugaB, et al
HER3 overexpression and survival in solid tumors: a meta-analysis. J Natl Cancer Inst
2013; 105: 266–273.23221996
,
OcanaAVera-BadilloFSerugaB, et al
HER3 overexpression and survival in solid tumors: a meta-analysis. J Natl Cancer Inst
2013; 105: 266–273.23221996
-
S.
Cousins,
E.
Tempest,
D.
Feuer
(2016)
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.
The Cochrane database of systematic reviews, 1
-
K.
Balamurugan
(2016)
HIF‐1 at the crossroads of hypoxia, inflammation, and cancer
International Journal of Cancer, 138
-
(
MiladinovicBMhaskarRHozoI, et al
Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error. J Clin Epidemiol
2013; 66: 654–659.23403248)
MiladinovicBMhaskarRHozoI, et al
Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error. J Clin Epidemiol
2013; 66: 654–659.23403248
,
MiladinovicBMhaskarRHozoI, et al
Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error. J Clin Epidemiol
2013; 66: 654–659.23403248
-
(
KalemkerianGPNarulaNKennedyEB, et al
Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American society of clinical oncology endorsement of the college of American pathologists/international association for the study of lung cancer/association for molecular pathology clinical practice guideline update. J Clin Oncol
2018; 36: 911–919.29401004)
KalemkerianGPNarulaNKennedyEB, et al
Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American society of clinical oncology endorsement of the college of American pathologists/international association for the study of lung cancer/association for molecular pathology clinical practice guideline update. J Clin Oncol
2018; 36: 911–919.29401004
,
KalemkerianGPNarulaNKennedyEB, et al
Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American society of clinical oncology endorsement of the college of American pathologists/international association for the study of lung cancer/association for molecular pathology clinical practice guideline update. J Clin Oncol
2018; 36: 911–919.29401004
-
Mariko
Shioya,
Takeo
Takahashi,
H.
Ishikawa,
H.
Sakurai,
T.
Ebara,
Yoshiyuki
Suzuki,
J.
Saitoh,
T.
Ohno,
T.
Asao,
H.
Kuwano,
T.
Nakano
(2011)
Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
Journal of radiation research, 52 6
-
(
Garcia-DonasJLeandro-GarciaLJGonzalez Del AlbaA, et al
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma. Ann Oncol
2013; 24: 2409–2414.23788753)
Garcia-DonasJLeandro-GarciaLJGonzalez Del AlbaA, et al
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma. Ann Oncol
2013; 24: 2409–2414.23788753
,
Garcia-DonasJLeandro-GarciaLJGonzalez Del AlbaA, et al
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma. Ann Oncol
2013; 24: 2409–2414.23788753
-
(
CousinsSETempestEFeuerDJ.
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev
2016; 1: CD002764.)
CousinsSETempestEFeuerDJ.
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev
2016; 1: CD002764.
,
CousinsSETempestEFeuerDJ.
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev
2016; 1: CD002764.